Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index; 2 of the 22 sources its claims cite were checked for support.

Efficacy of psychodynamic short-term psychotherapy for depressed breast cancer patients: Study protocol for a randomized controlled trial

Open access

Abstract

Background: There is a lack of psychotherapeutic trials of treatments of comorbid depression in cancer patients. Our study determines the efficacy of a manualized short-term psychodynamic psychotherapy and predictors of outcome by personality and quality of the therapeutic relationship.Methods/design: Eligible breast cancer patients with comorbid depression are assigned to short-term psychodynamic psychotherapy (up to 20 + 5 sessions) or to treatment as usual (augmented by recommendation for counseling center and physician information). We plan to recruit a total of 180 patients (90 per arm) in two centers. Assessments are conducted pretreatment, after 6 (treatment termination) and 12 months (follow-up). The primary outcome measures are reduction of the depression score in the Hospital Anxiety and Depression Scale and remission of depression as assessed by means of the Structured Clinical Interview for DSM IV Disorders by independent, blinded assessors at treatment termination. Secondary outcomes refer to quality of life.Discussion: We investigate the efficacy of short-term psychodynamic psychotherapy in acute care and we aim to identify predictors for acceptance and success of treatment.Trial registration: ISRCTN96793588. © 2012 Zwerenz et al.; licensee BioMed Central Ltd.

Overview

CoChat Summary

## TL;DR

This is a study protocol for a multicenter randomized controlled trial testing manualized short-term psychodynamic psychotherapy (STPP) for depressed breast cancer patients versus treatment as usual (TAU). The trial plans to enroll 180 patients and use remission of depression at treatment termination as the primary outcome.

## Key findings

  • The protocol plans to recruit 180 patients total (90 per arm) in two centers.
  • Eligible patients must have HADS depression score ≥ 8 and a depressive disorder diagnosis on SCID-I before randomization.
  • The primary outcome is remission of depression at treatment termination, defined as at least a 2-point reduction on the HADS depression score plus remission on SCID-I assessed by independent, blinded assessors.
  • The sample size calculation assumes 25% remission in TAU vs. 50% in STPP, and reports that detecting this 25% difference with power 0.80 requires N = 156, allowing for dropout.

## Methods

  • Design: Multicenter randomized prospective trial comparing STPP with TAU; assessments at baseline, 6 months (treatment termination), and 12 months (follow-up).
  • Sample/data: Breast cancer patients with comorbid depression recruited from Mainz and Leipzig with cooperating gynecological and oncological centers; only patients meeting HADS and SCID-I criteria are randomized.
  • Analysis: Primary endpoint analyzed with logistic regression including treatment, center, and baseline HADS as covariate; analyses follow an intention-to-treat approach, with dropouts counted as non-remitters.

## Limitations

  • The paper itself states this is a protocol and that, at the time of planning, “no meaningful published data” were available on remission rates for STPP vs. TAU in breast cancer depression.
  • The authors note that quality of care in the TAU condition may vary, which could affect comparisons.
  • Evident from the text: the paper reports planned methods and expected outcomes, not trial results, so no efficacy findings are available in this paper.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/1471-2407-12-578

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Study design and patient recruitment (N = projected numbers). Notes: a) Questionnaires filled out by the patients; b) Structured Clinical Interview for DSM-IV applied by trained interviewers; c) HADS score for depression ≥ 8 & SCID-I diagnosis estimated in 20% of the cases (N = 240 eligible patients) of whom 75% are expected to be consent with randomization; d) Expected completer 80%, e) Expected completer 70%.
Figure 1 Study design and patient recruitment (N = projected numbers). Notes: a) Questionnaires filled out by the patients; b) Structured Clinical Interview for DSM-IV applied by trained interviewers; c) HADS score for depression ≥ 8 & SCID-I diagnosis estimated in 20% of the cases (N = 240 eligible patients) of whom 75% are expected to be consent with randomization; d) Expected completer 80%, e) Expected completer 70%.CC BY · PubMed Central

Verification

Claims the paper makes

2 Valid · 0 Not valid · 12 Not checked · 9 Own results and interpretations

  • Probably not a substantial claim. 15
  • It may state two separate claims as one. 7

Create a free account to see these claims.

Citations

Cites

Show all 26 references

Research works printed but not linked: 5

  1. Hermann C, Buss U, Snaith R: HADS-D - Hospital Anxiety and Depression Scale - Deutsche Version: Ein Fragebogen zur Erfassung von Angst und Depressivität in der somatischen Medizin, Testdokumentation und Handanweisung. 1995, Bern: Huber
  2. Beutel M, Wiltink J, Hafner C, Reiner I, Bleichner F, Blatt S: Abhängigkeit und selbstkritik als psychologische dimensionen der depression - validierung der deutschsprachigen version des depressive experience questionnaire (DEQ). Z Kl Psych Psychiatr. 2004, 52: 1-14.
  3. Bassler M, Potratz B, Krauthauser H: Der “Helping Alliance Questionnaire” (HAQ) von Luborsky. Psychotherapeut. 1995, 40: 23-32.
  4. Wittchen H, Zaudig M, Fydrich T: SKID I - Strukturiertes Klinisches Interview für DSM-IV. 1997, Göttingen: Hogrefe
  5. Wiltink J, Edinger J, Haselbacher A, Imruck B, Beutel M: Adherence und competence in der psychotherapieforschung: neuere entwicklungen. Klin Diagn E. 2010, 3: 76-93.

Cited by

See all 25

Metadata

Authors
Zwerenz, R., Beutel, M. E., Imruck, B. H., Wiltink, J., Haselbacher, A., Ruckes, C., Schmidberger, H., Hoffmann, G., Schmidt, M., Köhler, U., Langanke, D., Kortmann, R.-D., Kuhnt, S., Weißflog, G., Barthel, Y., Leuteritz, K., & Brähler, E.
Affiliations
  • University Medical Center of the Johannes Gutenberg University Mainz (DE)
  • St. Josefs Hospital (DE)
  • Klinikum St. Georg (DE)
  • St. Elisabeth-Krankenhaus Leipzig (DE)
  • University Hospital Leipzig (DE)
  • Leipzig University (DE)
Corresponding author
Zwerenz, Rüdiger
Venue
BMC Cancer
Published
2012-12
Volume
12
Issue
1
Pages
578-578
ISSN
1471-2407 (ISSN-L)
OpenAlex
W2025360654
Cited by
25
References
26
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2022: 7 · 2021: 1 · 2017: 5 · 2016: 1 · 2015: 2 · 2013: 5
FWCI
1.11
Type
journal article
Language
en
Open access
Locations
  • BMC Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Deutsche Krebshilfe (107870 / 109381, 109381, 107457 / 109379, 107870, 107457, 109379)
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Topics
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
  • Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
Keywords
psychodynamic psychotherapy, brief psychotherapy, breast cancer, depression, comorbid depression, cancer patients, treatment outcome predictors, therapeutic relationship, personality, quality of life, depression remission, acute care
MeSH terms
Adolescent, Adult, Aged, Breast Neoplasms, Depression, Female, Follow-Up Studies, Humans, Middle Aged, Prospective Studies, Psychotherapy, Brief, Quality of Life, Comorbidity, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of psychodynamic short-term psychotherapy for depressed breast cancer patients: Study protocol for a randomized controlled trial. https://app.cochat.ai/papers/10.1186/1471-2407-12-578
The paper
Zwerenz, R., Beutel, M. E., Imruck, B. H., Wiltink, J., Haselbacher, A., Ruckes, C., Schmidberger, H., Hoffmann, G., Schmidt, M., Köhler, U., Langanke, D., Kortmann, R.-D., Kuhnt, S., Weißflog, G., Barthel, Y., Leuteritz, K., & Brähler, E. (2012). Efficacy of psychodynamic short-term psychotherapy for depressed breast cancer patients: Study protocol for a randomized controlled trial. BMC Cancer. https://doi.org/10.1186/1471-2407-12-578

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.